Edible THC Study Raises Questions About Early Brain Development

Edibles change how cannabis enters the body, but they do not remove its active compounds. That distinction matters during pregnancy, when avoiding smoke can easily be mistaken for avoiding every concern associated with cannabis exposure.

A new study in rhesus macaques, accepted for publication in Neurobiology of Disease, examines this question using daily edible THC rather than smoked cannabis.¹ Researchers observed differences in infant white matter development, emotional behavior, and molecular patterns in brain tissue. They did not find significant differences in regional brain volumes.

The findings warrant attention, but they are not a prediction of what will happen to an individual child. The more constructive lesson is that cannabis research is becoming better equipped to distinguish exposure routes, developmental timing, and biological mechanisms. That can support clearer guidance without turning uncertainty into alarm.

Why Edible THC Offers A Useful Research Model

Human pregnancy studies face a difficult problem: cannabis use can overlap with tobacco exposure, other substances, stress, medical conditions, and socioeconomic differences. Researchers can adjust for these factors, but observational studies cannot always untangle them completely.

The Oregon Health & Science University team used a controlled primate model to reduce several of these complications. Four mothers received a daily cookie containing research-grade THC, while four received a placebo cookie. Each group produced one male and three female infants.

THC dosing began before conception, increased gradually to 2.5 mg per 7 kg of body weight daily, and continued throughout pregnancy and after birth. Researchers followed brain development with MRI during gestation and infancy, observed behavior, and examined brain tissue at six months.

Using edibles removed combustion-related toxins from the experiment. Rhesus macaques also share relevant aspects of placental biology, brain development, and THC metabolism with humans, making them useful for investigating mechanisms that cannot ethically be tested through controlled pregnancy exposure in people.

However, this was a model of sustained exposure, not an occasional edible. Because maternal dosing continued after delivery, the experiment cannot isolate pregnancy exposure from postnatal influences. Its findings should be described as effects associated with maternal THC use across those periods.

What Changed In Infant Brain Development And Behavior?

At approximately one month, diffusion MRI did not reveal significant group differences in white matter fractional anisotropy. By six months, THC-exposed infants showed higher values in several regions, including the corpus callosum, which connects the brain’s two hemispheres.

Fractional anisotropy describes how directionally water moves through tissue. It can help researchers investigate white matter organization, but a higher value does not automatically mean healthier wiring, faster development, or brain damage. Different tissue characteristics can produce similar imaging changes.

The behavioral observations added another perspective. At three months, exposed infants spent more time on their mothers and less time moving independently. During later tests involving unfamiliar objects or a human intruder, they vocalized more. Researchers interpreted these patterns as consistent with increased stress or anxiety-related behavior.

Several other measurements did not show statistically significant differences, including hair cortisol and the immunohistochemical markers assessed. These results keep the interpretation specific. The study identified selected developmental differences, rather than a uniform pattern of abnormality across every test.

How THC May Influence The Developing Brain

The endocannabinoid system is involved in normal brain development. Its signaling helps regulate processes such as cell communication and the formation of neural connections. THC can interact with cannabinoid receptors, creating a plausible route through which exposure could influence developmental processes.

The researchers examined DNA methylation, chemical markings that help regulate gene activity without changing the DNA sequence. They identified exposure-associated differences in the cerebellum and prefrontal cortex, including regions linked to genes involved in nervous system development and synaptic organization.

Gene expression analysis provided a narrower result. Eight genes in the cerebellum remained statistically significant after correction for multiple comparisons. None did in the prefrontal cortex. Some broader pathway analyses used genes meeting less stringent, uncorrected thresholds, making those findings exploratory.

These molecular results provide candidates for further investigation. They do not establish that methylation changes caused the observed behavior. Likewise, overlap with genes listed in an autism research database does not show that exposed infants developed autism or establish that THC causes autism in humans.

Smoke-Free Cannabis Requires Its Own Safety Questions

The study highlights a broader weakness in consumer language: a product can avoid one exposure while retaining another. An edible avoids smoke inhalation, yet still delivers THC. Product format and developmental safety therefore require separate consideration.

Understanding how cannabis absorption changes with consumption method helps explain why swallowed and inhaled products are not interchangeable. Relevant questions include what enters circulation, how long exposure lasts, and which developmental windows are involved.

Adding CBD also cannot be assumed to neutralize THC. Recent MyCannabis coverage of CBD and THC interactions examines evidence that their combined effects on metabolism can be more complicated than a simple balancing relationship. That research concerns adult dosing, not pregnancy safety, but illustrates why cannabinoid ratios alone cannot settle safety questions.

This primate experiment tested THC, not CBD products. It cannot establish CBD as a safer substitute. The CDC’s pregnancy guidance notes that the potential effects of CBD products during pregnancy remain unknown and recommends avoiding cannabis during pregnancy.

Better Pregnancy Guidance Starts With Better Conversations

People may use cannabis to manage nausea, pain, sleep problems, or stress. Advice that addresses exposure without addressing those needs leaves an important part of the problem unresolved.

A recent JAMA Pediatrics patient guide explains that no known safe amount has been established during pregnancy or breastfeeding and encourages discussion of safer symptom-management options with a healthcare professional.

The practical opportunity is to make those conversations earlier, more specific, and easier to have. Useful topics include:

• The symptoms or circumstances driving cannabis use.
• The product, THC content, frequency, and timing of use.
• Alternative treatments and support for reducing or stopping use.

The American College of Obstetricians and Gynecologists’ updated pregnancy and lactation recommendations discourage cannabis use while emphasizing counseling and support. They also state that continued use is not a contraindication to breastfeeding. That distinction deserves individualized clinical discussion rather than an automatic instruction to stop breastfeeding.

For someone who has already used cannabis, this study cannot determine whether their child has been affected. Its value is in informing future decisions and research, rather than assigning an outcome to a past exposure.

What Future Cannabis Pregnancy Research Should Resolve

Eight infants cannot capture the full range of biological variation. The study lacked power to investigate sex-specific effects, and tissue-level molecular measurements combined signals from different cell types. Some imaging processing was also performed without explicit blinding to treatment.

Larger studies should separate prenatal and postnatal exposure, investigate different dosing patterns, and follow development for longer. Single-cell and spatial analyses could clarify which cells contribute to the molecular differences. Repeated behavioral and functional imaging assessments could reveal whether early changes persist, diminish, or shift over time.

The encouraging development is methodological: researchers can connect controlled exposure with imaging, behavior, and molecular biology in the same animals. That creates a stronger foundation for testing mechanisms and interpreting human observations.

Responsible cannabis coverage can recognize that progress while preserving uncertainty. This study strengthens the case for taking maternal THC exposure seriously. It also shows a path toward more precise guidance, better symptom-management support, and decisions grounded in evidence rather than assumptions about smoke-free products.

References:

¹ D’Mello, R. J., Shorey-Kendrick, L. E., Karpf, J. A., Chan, C. N., Grafe, M. R., Edenfield, R. C., Graham, J. A., Hagen, O. L., Manuzak, J. A., Burwitz, B. J., Hedges, J. C., Spindel, E. R., Grant, K. A., Kroenke, C. D., Sullivan, E. L., & Lo, J. O. (2026). Maternal edible THC consumption alters offspring neurodevelopment and emotional behavior in rhesus macaques. Neurobiology of Disease. Advance online publication. https://doi.org/10.1016/j.nbd.2026.107640